A pyrene-based HDAC inhibitor for dual-action therapy of breast cancer

Here we report PySAHA, a multifunctional HDAC inhibitor, which can uniquely degrade HDACs within cells via a hydrophobic tagging mechanism, and also possesses photodynamic therapeutic activity. The synergistic interplay of these dual functionalities results in potent anti-breast cancer efficacy.